Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Neha J Pagidipati (Duke University Medical Center, US) and Dr Christopher B Granger (Duke University Medical Center, US) to discuss the results of the COORDINATE-Diabetes trial.

The COORDINATE-Diabetes trial is testing a multifaceted intervention to improve the care of people with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD).
The trial involves cardiology clinics in the US and provides a multi-disciplinary approach to care, including education for clinicians and patients, patient tracking, and monthly clinician calls to review cases. The primary outcome is the proportion of patients receiving all three types of recommended medication (high-intensity statin, ACEi/ARB, and SGLT2i or GLP1RA) at the last follow-up visit.
The trial showed that a coordinated, multifaceted intervention increased prescription of 3 groups of evidence-based therapies in adults with T2DM and ASCVD.

Recorded remotely from Hamilton and Durham, 2023.

Visit Radcliffe Cardiology:

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:
Follow us on Twitter:

Чтобы скачать видео "ACC 23 Late-Breaker Discussion: The COORDINATE-Diabetes Trial" передвинте ползунок вправо